- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有106家主力机构披露2025-12-31报告期持股数据，持仓量总计8.15亿股，占流通A股60.75%
- 波段诊断：
-
技术面诊股
诊断结果：6.1技术面打败了59%的股票
技术面评分前10的股票
近期的平均成本为8.82元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为8.82元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"8.82","date":1785399347,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑赢行业平均水平。
[{"date":"2026.07.31","stock":"0.00","trade":"1.69","ind":"0.72"},{"date":"2026.07.30","stock":"1.61","trade":"-1.97","ind":"-0.62"},{"date":"2026.07.29","stock":"1.05","trade":"0.51","ind":"0.40"},{"date":"2026.07.28","stock":"-0.58","trade":"-1.30","ind":"-1.16"},{"date":"2026.07.27","stock":"2.24","trade":"3.35","ind":"1.15"},{"date":"2026.07.24","stock":"-2.53","trade":"-4.36","ind":"-1.61"},{"date":"2026.07.23","stock":"-0.80","trade":"0.60","ind":"0.25"},{"date":"2026.07.22","stock":"0.57","trade":"0.08","ind":"0.07"},{"date":"2026.07.21","stock":"-2.13","trade":"-1.41","ind":"1.79"},{"date":"2026.07.20","stock":"0.45","trade":"-0.39","ind":"0.85"},{"date":"2026.07.17","stock":"-4.01","trade":"-7.15","ind":"-3.05"},{"date":"2026.07.16","stock":"1.54","trade":"0.97","ind":"-1.85"},{"date":"2026.07.15","stock":"2.13","trade":"3.85","ind":"-0.29"},{"date":"2026.07.14","stock":"1.14","trade":"2.69","ind":"1.36"},{"date":"2026.07.13","stock":"1.27","trade":"-0.42","ind":"-2.06"},{"date":"2026.07.10","stock":"1.52","trade":"3.20","ind":"-1.00"},{"date":"2026.07.09","stock":"-1.61","trade":"-0.42","ind":"1.65"},{"date":"2026.07.08","stock":"0.58","trade":"-1.44","ind":"-0.49"},{"date":"2026.07.07","stock":"-3.78","trade":"-4.17","ind":"-1.26"},{"date":"2026.07.06","stock":"0.78","trade":"0.97","ind":"-0.06"},{"date":"2026.07.03","stock":"0.79","trade":"1.73","ind":"0.37"}]
国药现代,上证指数,化学制药指数
压力支撑
该股压力位为8.79元，支撑位为8.71元。
[{"text":"\u538b\u529b\u4f4d","value":"8.79","date":1785427200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"8.71","date":1785427200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.9资金面打败了61%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：07月31日 16:36
| 机构今日流向(万元) | 313.73 | 机构5日流向(万元) | -1324.23 |
| 机构10日流向(万元) | -4906.30 | 机构20日流向(万元) | -8943.80 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少2046.18万股，其中基金净减仓16家，主力净减仓75家，请投资者中长期谨慎为宜。
截止2025-12-31，共106家主力机构（基金98家，一般法人8家），持仓量总计81471.68万股，占流通A股60.75%
其中，基金持仓与2025-06-30相比：
增仓：20家 ，增持 158.08万股
减仓：36家 ，减持 281.98万股
新出现在主力名单中：30家 ，持有1029.58万股
从主力名单中消失：105家 ，原持有2951.86万股
其中，基金持仓与2025-06-30相比：
增仓：20家 ，增持 158.08万股
减仓：36家 ，减持 281.98万股
新出现在主力名单中：30家 ，持有1029.58万股
从主力名单中消失：105家 ，原持有2951.86万股
消息面诊股
诊断结果：3.9消息面打败了5%的股票
今日有利好新闻的公司
近期利空消息较多且有重大利空，消息面发出消极信号。
更多>>个股资讯
- 国药现代：7月30日获融资买入723.19万元
2026-07-31 - 国药现代：乳果糖口服溶液上市许可持有人变更为子公司
2026-07-30 - 国药现代：7月29日获融资买入643.17万元
2026-07-30 - 国药现代：7月28日获融资买入816.03万元
2026-07-29 - 国药现代：公司披露了《未来三年（2025-2027
2026-07-28 - 国药现代：公司发展主业及不断做强主业，需要持续开展
2026-07-28 - 国药现代：公司将坚持以提升经营质量和内在价值为核心
2026-07-28 - 国药现代：我们认同您关于公司的管理发展逻辑
2026-07-28 - 国药现代：公司将积极贯彻国药集团有关工作部署及要求
2026-07-28 - 国药现代：未来三年现金分红比例不低于归母净利润的4
2026-07-28
消息列表
| 一般消息 | 募资投向 | 公司购买资产 | 2026-07-31 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2026-07-11 |
| 一般消息 | 重大事项 | 关联交易 | 2026-05-09 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2026-04-11 |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-03-28 |
| 利好 | 分红转增 | 10派2元(含税) | 2026-03-28 |
| 一般消息 | 重大事项 | 关联交易 | 2026-03-28 |
| 一般消息 | 募资投向 | 公司出售资产 | 2026-03-25 |
| 一般消息 | 高管变动 | 任期届满不再担任 | 2025-12-24 |
| 一般消息 | 高管变动 | 工作调动 | 2025-10-09 |
| 利好 | 分红转增 | 10派1元(含税) | 2025-08-30 |
| 一般消息 | 高管变动 | 达到退休年龄 | 2025-08-03 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 2条 | 2条 | 0条 |
行业面诊股
诊断结果：5.2行业面打败了70%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，明显跑输大盘。
[{"date":"2026.07.31","price":"0.72","value":"1.69"},{"date":"2026.07.30","price":"-0.62","value":"-1.97"},{"date":"2026.07.29","price":"0.40","value":"0.51"},{"date":"2026.07.28","price":"-1.16","value":"-1.30"},{"date":"2026.07.27","price":"1.15","value":"3.35"},{"date":"2026.07.24","price":"-1.61","value":"-4.36"},{"date":"2026.07.23","price":"0.25","value":"0.60"},{"date":"2026.07.22","price":"0.07","value":"0.08"},{"date":"2026.07.21","price":"1.79","value":"-1.41"},{"date":"2026.07.20","price":"0.85","value":"-0.39"},{"date":"2026.07.17","price":"-3.05","value":"-7.15"},{"date":"2026.07.16","price":"-1.85","value":"0.97"},{"date":"2026.07.15","price":"-0.29","value":"3.85"},{"date":"2026.07.14","price":"1.36","value":"2.69"},{"date":"2026.07.13","price":"-2.06","value":"-0.42"},{"date":"2026.07.10","price":"-1.00","value":"3.20"},{"date":"2026.07.09","price":"1.65","value":"-0.42"},{"date":"2026.07.08","price":"-0.49","value":"-1.44"},{"date":"2026.07.07","price":"-1.26","value":"-4.17"},{"date":"2026.07.06","price":"-0.06","value":"0.97"},{"date":"2026.07.03","price":"0.37","value":"1.73"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 哈药股份 | 87.58% | 9.07% | 6.8分 |
| 2 | 哈三联 | 15.18% | 0.53% | 5.4分 |
| 3 | 永安药业 | 14.61% | 7.22% | 5.5分 |
| 4 | 普洛药业 | 10.86% | 2.74% | 6.3分 |
| 5 | 恩华药业 | 10.61% | 5.79% | 6.3分 |
| 6 | 海正药业 | 9.97% | 0.17% | 6.0分 |
| 8 | 华海药业 | 8.50% | 4.43% | 6.4分 |
| 10 | 鲁抗医药 | 6.66% | 3.80% | 5.9分 |
| 12 | 健友股份 | 5.89% | 7.15% | 5.2分 |
| 14 | 华北制药 | 5.01% | 3.21% | 5.8分 |
| 16 | 立方制药 | 3.82% | 8.14% | 5.2分 |
| 18 | 石药创新 | 3.57% | 3.04% | 5.2分 |
| 20 | 国邦医药 | 3.05% | 4.57% | 5.0分 |
| 22 | 华特达因 | 2.48% | 5.10% | 5.5分 |
| 24 | 亿帆医药 | 2.39% | 4.80% | 6.1分 |
| 26 | 仙琚制药 | 2.27% | 4.51% | 5.9分 |
| 28 | 川宁生物 | 2.11% | 4.18% | 5.8分 |
| 30 | 神奇制药 | 2.08% | 4.47% | 5.8分 |
| 32 | 金陵药业 | 1.78% | 4.66% | 5.9分 |
| 34 | 东北制药 | 1.55% | 1.78% | 5.3分 |
| 36 | 海普瑞 | 1.47% | 3.75% | 5.3分 |
| 38 | 新天地 | 1.14% | 2.97% | 4.5分 |
| 40 | 亚虹医药 | 0.80% | -9.70% | 4.1分 |
| 42 | 辰欣药业 | 0.57% | 1.81% | 4.7分 |
| 44 | 新和成 | 0.03% | 0.87% | 5.3分 |
| 46 | ST南新 | -0.16% | -4.63% | 3.8分 |
| 48 | 津药药业 | -0.19% | 6.61% | 4.9分 |
| 50 | - | -0.44% | 9.36% | 分 |
| 52 | 恒瑞医药 | -0.68% | 1.18% | 5.8分 |
| 54 | 东诚药业 | -0.77% | 3.47% | 6.2分 |
| 56 | 北大医药 | -0.95% | 4.63% | 5.4分 |
| 58 | - | -1.22% | 5.18% | 分 |
| 60 | - | -1.43% | 5.98% | 分 |
| 62 | 同和药业 | -2.47% | 4.67% | 5.3分 |
| 64 | 山河药辅 | -2.57% | 5.02% | 5.2分 |
| 66 | 拓新药业 | -2.80% | 5.42% | 5.2分 |
| 68 | 金城医药 | -3.30% | 5.49% | 6.1分 |
| 70 | 通化金马 | -3.42% | 12.62% | 5.8分 |
| 72 | 广济药业 | -3.65% | 7.35% | 5.4分 |
| 74 | 百济神州 | -3.71% | -5.15% | 5.4分 |
| 76 | 民生健康 | -3.75% | 5.33% | 5.4分 |
| 78 | ST能特 | -4.22% | -2.16% | 4.9分 |
| 80 | 康芝药业 | -4.70% | 8.09% | 5.5分 |
| 82 | 冀衡医药 | -5.41% | 7.03% | 5.5分 |
| 84 | 富士莱 | -5.51% | 6.39% | 4.1分 |
| 86 | 力生制药 | -5.70% | 3.34% | 5.1分 |
| 88 | 北陆药业 | -5.90% | 5.68% | 5.6分 |
| 90 | 诚意药业 | -6.32% | 2.74% | 4.5分 |
| 92 | 复旦张江 | -6.43% | 2.97% | 4.8分 |
| 94 | - | -7.17% | -4.09% | 分 |
| 96 | 微芯生物 | -7.93% | -6.17% | 4.7分 |
| 98 | 吉贝尔 | -8.39% | 5.41% | 5.2分 |
| 100 | 凯因科技 | -8.83% | 5.85% | 4.7分 |
| 102 | - | -9.38% | 5.98% | 分 |
| 104 | 天宇股份 | -9.53% | 1.12% | 4.6分 |
| 106 | 仟源医药 | -9.69% | 7.70% | 5.3分 |
| 108 | 京新药业 | -10.20% | 1.34% | 5.7分 |
| 110 | 美诺华 | -10.47% | -5.54% | 4.4分 |
| 112 | 向日葵 | -11.08% | 7.66% | 4.3分 |
| 114 | 益方生物 | -11.42% | -15.33% | 4.2分 |
| 116 | 双鹭药业 | -11.91% | 6.24% | 5.3分 |
| 118 | 宣泰医药 | -12.22% | 1.10% | 4.6分 |
| 120 | 东亚药业 | -12.37% | 9.29% | 4.1分 |
| 122 | 海森药业 | -12.68% | 4.36% | 4.6分 |
| 124 | 金石亚药 | -13.32% | -0.30% | 4.8分 |
| 126 | 奥赛康 | -13.87% | 3.82% | 5.9分 |
| 128 | 一品红 | -14.51% | 4.28% | 5.3分 |
| 130 | 艾力斯 | -15.04% | -6.74% | 5.6分 |
| 132 | 多瑞医药 | -15.47% | -0.80% | 4.0分 |
| 134 | 纳微科技 | -15.69% | -3.58% | 5.6分 |
| 136 | 威尔药业 | -16.12% | -0.30% | 4.4分 |
| 138 | 海辰药业 | -16.52% | 1.05% | 4.7分 |
| 140 | 信立泰 | -16.97% | 3.39% | 5.2分 |
| 142 | 广生堂 | -17.21% | 2.72% | 4.7分 |
| 144 | 海思科 | -18.43% | -5.66% | 5.5分 |
| 146 | 华纳药厂 | -20.32% | -6.12% | 4.6分 |
| 148 | 汇宇制药 | -20.95% | 3.88% | 4.7分 |
| 150 | 苑东生物 | -21.61% | -8.69% | 4.3分 |
| 152 | 富祥股份 | -24.93% | -3.58% | 4.3分 |
| 154 | 宏源药业 | -30.26% | 1.41% | 4.1分 |
| 156 | 必贝特 | -37.91% | -30.52% | 4.3分 |
| 158 | 花园生物 | -42.90% | 3.16% | 3.7分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 87/216 ， 113/216。
[{"date":"2026-03-31","value":"1.00","vol":"0.45"},{"date":"2025-12-31","value":"6.98","vol":"-1.85"},{"date":"2025-09-30","value":"5.97","vol":"1.60"},{"date":"2025-06-30","value":"5.01","vol":"1.26"},{"date":"2025-03-31","value":"2.70","vol":"-0.13"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
1.00 | 6.98 | 5.97 | 5.01 | 2.70 |
| 行业(%) | 0.45 | -1.85 | 1.60 | 1.26 | -0.13 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"30.20","vol":"50.98"},{"date":"2025-12-31","value":"32.43","vol":"49.96"},{"date":"2025-09-30","value":"33.29","vol":"49.79"},{"date":"2025-06-30","value":"36.03","vol":"49.69"},{"date":"2025-03-31","value":"37.10","vol":"49.05"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
30.20 | 32.43 | 33.29 | 36.03 | 37.10 |
| 行业(%) | 50.98 | 49.96 | 49.79 | 49.69 | 49.05 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 135/216 ， 133/216。
[{"date":"2026-03-31","value":"-20.81","vol":"24.44"},{"date":"2025-12-31","value":"-14.39","vol":"38.58"},{"date":"2025-09-30","value":"-19.47","vol":"142.64"},{"date":"2025-06-30","value":"-18.16","vol":"79.18"},{"date":"2025-03-31","value":"-16.54","vol":"0.16"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-20.81 | -14.39 | -19.47 | -18.16 | -16.54 |
| 行业(%) | 24.44 | 38.58 | 142.64 | 79.18 | 0.16 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"-61.71","vol":"52.58"},{"date":"2025-12-31","value":"-13.11","vol":"-24.51"},{"date":"2025-09-30","value":"-16.07","vol":"3.72"},{"date":"2025-06-30","value":"-6.46","vol":"66.32"},{"date":"2025-03-31","value":"9.10","vol":"-9.37"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-61.71 | -13.11 | -16.07 | -6.46 | 9.10 |
| 行业(%) | 52.58 | -24.51 | 3.72 | 66.32 | -9.37 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 58/216 ， 38/216。
[{"date":"2026-03-31","value":"0.11","vol":"0.10"},{"date":"2025-12-31","value":"0.48","vol":"0.41"},{"date":"2025-09-30","value":"0.35","vol":"0.31"},{"date":"2025-06-30","value":"0.25","vol":"0.21"},{"date":"2025-03-31","value":"0.13","vol":"0.10"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.11 | 0.48 | 0.35 | 0.25 | 0.13 |
| 行业(次) | 0.10 | 0.41 | 0.31 | 0.21 | 0.10 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.80","vol":"0.64"},{"date":"2025-12-31","value":"3.20","vol":"2.56"},{"date":"2025-09-30","value":"2.20","vol":"1.94"},{"date":"2025-06-30","value":"1.44","vol":"1.30"},{"date":"2025-03-31","value":"0.76","vol":"0.66"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.80 | 3.20 | 2.20 | 1.44 | 0.76 |
| 行业(次) | 0.64 | 2.56 | 1.94 | 1.30 | 0.66 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"-17.60","vol":"-2.75"},{"date":"2025-12-31","value":"22.78","vol":"16.48"},{"date":"2025-09-30","value":"23.19","vol":"4.59"},{"date":"2025-06-30","value":"15.99","vol":"2.93"},{"date":"2025-03-31","value":"11.69","vol":"-26.34"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -17.60 | 22.78 | 23.19 | 15.99 | 11.69 |
| 行业 | -2.75 | 16.48 | 4.59 | 2.93 | -26.34 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.36","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.39","vol":"1.72"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.36 | - | 0.39 | - |
| 行业 | 0.00 | 1.60 | 0.00 | 1.72 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 102/216 ， 76/216。
[{"date":"2026-03-31","value":"3.59","vol":"3.58"},{"date":"2025-12-31","value":"3.59","vol":"3.33"},{"date":"2025-09-30","value":"3.21","vol":"3.50"},{"date":"2025-06-30","value":"2.93","vol":"3.68"},{"date":"2025-03-31","value":"3.32","vol":"3.58"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
3.59 | 3.59 | 3.21 | 2.93 | 3.32 |
| 行业 | 3.58 | 3.33 | 3.50 | 3.68 | 3.58 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"1.76","vol":"2.94"},{"date":"2025-12-31","value":"1.68","vol":"2.71"},{"date":"2025-09-30","value":"1.71","vol":"2.75"},{"date":"2025-06-30","value":"1.75","vol":"2.90"},{"date":"2025-03-31","value":"2.07","vol":"2.81"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
1.76 | 1.68 | 1.71 | 1.75 | 2.07 |
| 行业 | 2.94 | 2.71 | 2.75 | 2.90 | 2.81 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 111/216 ， 107/216。
[{"date":"2026-03-31","value":"17.59","vol":"33.40"},{"date":"2025-12-31","value":"17.59","vol":"34.57"},{"date":"2025-09-30","value":"18.79","vol":"34.00"},{"date":"2025-06-30","value":"20.32","vol":"34.11"},{"date":"2025-03-31","value":"18.54","vol":"34.06"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
17.59 | 17.59 | 18.79 | 20.32 | 18.54 |
| 行业(%) | 33.40 | 34.57 | 34.00 | 34.11 | 34.06 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.25","vol":"9.83"},{"date":"2025-12-31","value":"0.25","vol":"1.77"},{"date":"2025-09-30","value":"0.27","vol":"1.19"},{"date":"2025-06-30","value":"0.29","vol":"0.88"},{"date":"2025-03-31","value":"0.26","vol":"1.44"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.25 | 0.25 | 0.27 | 0.29 | 0.26 |
| 行业(%) | 9.83 | 1.77 | 1.19 | 0.88 | 1.44 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"6.28","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"6.92","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"10.84","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"9.42","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"8.50","blueLineValue":"0.63","type":"YC"}]